stars 1 stars 2 stars 3

Neovacs, a French Biotechnology company, develops therapeutic vaccines for the treatment of autoimmune, inflammatory diseases aand invests in innovative companies (Biotech and Medtech).

NEOVACS Questions

The NEOVACS annual revenue was $750000 in 2026.

Olivier Dhellin is the director pharmaceutical development of NEOVACS.

13 people are employed at NEOVACS.

NEOVACS is based in Suresnes, Île-de-France.

The NAICS codes for NEOVACS are [54171, 541, 54, 541713, 5417].

The SIC codes for NEOVACS are [87, 873].

Top NEOVACS Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users